SKYSTAR BIO-PHARMACEUTICAL CO Accounts Receivable
SKYSTAR BIO-PHARMACEUTICAL CO had Accounts Receivable of $35.35 million as of 2014-09-30, per its 10-Q filed 2014-11-14.
Discontinued › Balance Sheet › Assets › Assets, Current › Accounts and Financing Receivable, after Allowance for Credit Loss, Current › Accounts Receivable, after Allowance for Credit Loss, Current
us-gaap:AccountsReceivableNetCurrent · last filed 2014-11-14
- 2014-09-30: Accounts Receivable, after Allowance for Credit Loss, Current $35.35M.
- 2014-06-30: Accounts Receivable, after Allowance for Credit Loss, Current $18.95M.
- 2014-03-31: Accounts Receivable, after Allowance for Credit Loss, Current $12.66M.
- 2013-12-31: Accounts Receivable, after Allowance for Credit Loss, Current $11.01M.
| Period end | Accounts Receivable, after Allowance for Credit Loss, Current |
|---|---|
| 2014-09-30 | $35.35M 10-Q · filed 2014-11-14 |
| 2014-06-30 | $18.95M 10-Q · filed 2014-08-14 |
| 2014-03-31 | $12.66M 10-Q · filed 2014-05-15 |
| 2013-12-31 | $11.01M 10-Q · filed 2014-11-14 |
| 2013-09-30 | $26.90M 10-Q · filed 2013-11-14 |
| 2013-06-30 | $11.93M 10-Q · filed 2013-08-14 |
| 2013-03-31 | $11.44M 10-Q · filed 2013-05-15 |
| 2012-12-31 | $10.01M 10-K · filed 2014-03-31 |
| 2012-09-30 | $15.46M 10-Q · filed 2012-11-14 |
| 2012-06-30 | $10.69M 10-Q/A · filed 2012-09-13 |
| 2012-03-31 | $5.78M 10-Q · filed 2012-05-15 |
| 2011-12-31 | $3.39M 10-K · filed 2013-04-01 |
| 2011-09-30 | $9.77M 10-Q · filed 2011-11-14 |
| 2011-06-30 | $3.98M 10-Q/A · filed 2011-09-21 |
| 2010-12-31 | $4.98M 10-K · filed 2012-03-30 |
| 2010-12-30 | $4.98M 10-Q · filed 2011-11-14 |